TY  - JOUR

T1  - Bone mineral density as a surrogate endpoint for fracture risk reduction in clinical trials of osteoporosis therapies: an update on SABRE

JO  - The Lancet Diabetes & Endocrinology

UR  - http://dx.doi.org/10.1016/s2213-8587(24)00092-5

PY  - 2024/04/24

AU  - Black DM

AU  - Thompson AR

AU  - Eastell R

AU  - Bouxsein ML

ED  - 

DO  - DOI: 10.1016/s2213-8587(24)00092-5

PB  - Elsevier BV

Y2  - 2024/12/23

ER  -